NOVOTECH HEALTH HOLDINGS PTE LTD
Associated tags: Drug development, Fine chemical
Locations: SOUTH CAROLINA, APAC, AUSTRALIA, INDIA, SOUTH AFRICA, PA, TOKYO, WASHINGTON, SINGAPORE, JAPAN, AFRICA, SWITZERLAND, BEIJING, MIDDLE EAST, AMERICAS, IL, SEOUL, NEW ZEALAND, TAIWAN, KOREA, ASIA, US, CHINA
Novotech 主持关于如何建立和资助东西方 MRCT 战略的 BioCentury 峰会研讨会
Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy
Novotech has significant real-world experience in East-West MRCT strategy after more than 2 decades managing clinical research programs for biotechs across Asia Pacific and the US.
- Novotech has significant real-world experience in East-West MRCT strategy after more than 2 decades managing clinical research programs for biotechs across Asia Pacific and the US.
- Commenting on Novotech's experience, Chief Commercial Officer Barry Murphy said the right drug development pathway supports investor attraction and a successful clinical program.
- Strategies for an East-West MRCT include:
- Companies should engage with the US FDA and NMPA early to confirm guidance on their clinical roadmap. - Novotech has integrated labs and phase I facilities and provides drug development consulting and clinical development services across all phases.
Clinical Research Opportunities in China and the Path to USFDA Approval - Whitepaper
The report was prepared for international biotechs considering China for their clinical research, as well as China biotechs conducting research in China, and the relevant processes required for USFDA approvals.
- The report was prepared for international biotechs considering China for their clinical research, as well as China biotechs conducting research in China, and the relevant processes required for USFDA approvals.
- Novotech's Vice President, Global Head of Clinical Services Dr. Yooni Kim said: "China presents exceptional clinical opportunities with vast populations and word-class research facilities and KOLs.
- This concise analysis of the pathway to USFDA approval expertly informs clinical stage biotechs about the China research benefits and how to manage any challenges.
- The report details the regulatory requirements for biotechs including NDA and IND processes as well as ex-US research guidance for a successful USFDA approval pathway.
The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval
SYDNEY, AU, Oct 17, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO, and Endpoints News present a webinar for biotechs considering the clinical research opportunities in Asia Pacific and the regulatory pathways to achieving FDA approval.
- SYDNEY, AU, Oct 17, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO, and Endpoints News present a webinar for biotechs considering the clinical research opportunities in Asia Pacific and the regulatory pathways to achieving FDA approval.
- Novotech has operations across Asia Pacific and the US offering a unique and unparalleled suite of CRO services for early to late phase biotech clinical research.
- Consistent investment in advanced training and technology systems combine to deliver a specialist full-service biotech CRO solution.
- Novotech has integrated labs and phase I facilities and provides drug development consulting and clinical development services across all phases.
노보텍 인디아, ‘글로벌 근로 표준 당국’으로부터 “2022년 여성을 위한 최고의 직장”으로 선정
Novotech India 被全球工作标准局评为“2022 年女性最佳工作场所”
Novotech India Recognised as "Best Workplaces for Women 2022" by Global Work Standards Authority
To identify India's Best Workplaces for Women 2022, Great Place to Work India studied 1122 organizations that had:
- To identify India's Best Workplaces for Women 2022, Great Place to Work India studied 1122 organizations that had:
According to Great Place to Work India: "We have observed that the Best Workplaces have gone above and beyond to create and sustain aspirational organizations. - We congratulate Novotech for being a role-model in India by fostering an equal and equitable workplace culture."
- Novotech CEO Dr. John Moller said: "As a leading employer of women in India we are extremely pleased to be ranked among the top companies in India as a Best Workplaces for Women 2022.
- Novotech's Chief People Officer Angela Edwardson said: "We are delighted that Novotech India has been recognized as a leading employer for women.